Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026)

Astrazeneca has reported FCF Payout Ratio for 18 years, with the latest figure at 0.0 in Q2 2026.

• On a quarterly basis, FCF Payout Ratio rose 88.85% year-over-year to 0.0 in Q2 2026; TTM through Jun 2026 was 0.29, a 7.4% increase from a year earlier, with the FY2025 full-year figure at 0.29, up 14.85% from the prior year.
• FCF Payout Ratio was 0.0 for Q2 2026 at Astrazeneca, up from 0.84 in the prior quarter.
• The five-year high for FCF Payout Ratio was 0.0 in Q2 2026, with the low at 1.04 in Q1 2024.
• Average FCF Payout Ratio over 5 years is 0.4, with a median of 0.28 recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: FCF Payout Ratio dropped 15.9% in 2024, then soared 88.85% in 2026.
• Over 5 years, FCF Payout Ratio stood at 0.86 in 2022, then jumped by 98.71% to 0.01 in 2023, then jumped by 92.5% to 0.0 in 2024, then slipped by 7.02% to 0.0 in 2025, then jumped by 68.96% to 0.0 in 2026.
• The last three FCF Payout Ratio figures came in at 0.0 (Q2 2026), 0.84 (Q1 2026), and 0.0 (Q4 2025), per Business Quant data.